Articles by Nico Gagelmann, MD
CAR-T therapy, while complex and expensive, has better PFS than autologous or allogenic stem cell transplantation.
CALR and MPL mutations, which are associated with better outcomes, showed earlier mutation clearance than JAK2.
Dr. Gagelmann outlines the challenges that he sees in Europe and across the globe for young researchers and clinicians.
Dr. Gagelmann outlines key highlights of the session, his presentation and what he hopes attendees learned from the session.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.